Eurocine Vaccines discloses year-end report for the fiscal year 2021/2022
Eurocine Vaccines AB (publ) (”Eurocine Vaccines) hereby discloses the year-end report for the fiscal year 2021/2022. Below is a summary of the report. The full report is available on the Eurocine Vaccines website and as an attachment. 2022-04-01 - 2022-06-30 (fourth quarter) · Results after tax for the quarter amounted to -5,2 MSEK (-6,1 MSEK) · Revenues for the quarter amounted to 43 KSEK (2 KSEK) · Earnings per share for the quarter amounted to -0,299 SEK (-0,768 SEK) 2021-07-01 - 2022-03-31 (fiscal year, twelve months) · Results after